ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE recommends Revlimid for newly diagnosed multiple myeloma patients
January 27, 2021Bristol Myers Squibb’s (BMS) Revlimid (lenalidomide) has received a recommendation from the UK’s National Institute of Health and Care Excellence (NICE) for newly diagnosed multiple myeloma patients. -
ASCT May Offer Alternative for Tx of High-Risk Follicular Lymphoma
July 26, 2019Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk... -
Darzalex “significantly reduces” disease progression and death in multiple myeloma at ASH 2018
December 07, 2018Janssen has taken the opportunity at the American Society of Hematology (ASH) Annual Meeting 2018 to unveil new Phase 3 data for its combination of Darzalex (daratumumab) alongside lenalidomide
Pharma Sources Insight January 2025
